Protean agonism at α(2A)-adrenoceptors

Molecular Pharmacology

Volumn 53, Issue 5, 1998, Pages 963-968

  Jansson, Christian C ^a,b   Kukkonen, Jyrki P ^a,c   Näsman, Johnny ^c   Huifang, Ge ^a,b   Wurster, Siegfried ^b,d   Virtanen, Raimo ^d   Savola, Juha Matti ^d   Cockcroft, Vic ^d   Åkerman, Karl E O ^c,e  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UPPSALA UNIVERSITY   (Sweden)

^d ORION CORPORATION   (Finland)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

[4 (5 FLUORO 2,3 DIHYDRO 1H INDEN 2 YL) 1H IMIDAZOLE]HYDROCHLORIDE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ATIPAMEZOLE; BRIMONIDINE; CALCIUM ION; CLONIDINE; DESIPRAMINE; DEXMEDETOMIDINE; GUANINE NUCLEOTIDE BINDING PROTEIN; IDAZOXAN; LEVOMEDETOMIDINE; MEDETOMIDINE; MPV 2088; PERTUSSIS TOXIN; RAUWOLSCINE; UNCLASSIFIED DRUG; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CYCLIC AMP; IMIDAZOLE DERIVATIVE; INDENE DERIVATIVE; MPV 1743 AIII; RECEPTOR, ADRENERGIC, ALPHA 2A; RECEPTOR, ADRENERGIC, ALPHA-2A;

ALPHA ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STEREOISOMERISM; VAS DEFERENS;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CALCIUM; CYCLIC AMP; HUMANS; IMIDAZOLES; INDENES; MALE; MEDETOMIDINE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; STEREOISOMERISM; TUMOR CELLS, CULTURED; VAS DEFERENS;

EID: 0031596989     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 2+)-ATPase activity of human erythrocyte ghosts. Biochim Biophys Acta 845:48-53.
2. 2-adrenoceptors in mammalian cells. J Biotechnol 37:179-184.
3. Alkorta I and Du P (1994) Sequence divergence analysis for the prediction of seven-helix membrane protein structures: a 3-D model of human rhodopsin. Protein Eng 7:1231-1238.
4. 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA 88:11354-11358.
5. Arnis S and Hofmann KP (1995) Photoregeneration of bovine rhodopsin from its signaling state. Biochemistry 34:9333-9340.
6. 2c receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem 269:11687-11690.
7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Chem 72:248-254.
8. 2-adrenergic receptor. Mol Pharmacol 50:662-669.
9. Costa T and Herz A (1989) Antagonists with negative intrinsic activity at δ opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86:7321-7325.
10. Dohlman HG and Thorner J (1997) RGS proteins and signaling by heterotrimeric G proteins. J Biol Chem 272:3871-3874.
11. Farahbakhsh ZT, Ridge KD, Khorana HG, and Hubbell WL (1995) Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. Biochemistry 34:8812-8819.
12. 1C-subtypes. Biochem Biophys Res Commun 186:760-767.
13. 2 adrenergic receptor: evidence for ligand-specific conformational changes. J Biol Chem 270:28268-28275.
14. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
15. Hancock AA, Kyncl JJ, Martin YC, and DeBernadis JF (1988) Differentiation of α-adrenergic receptors using pharmacological evaluation and molecular modeling of selective adrenergic agents. J Recept Res 8:23-46.
16. 2-adrenoceptor subtypes to regulation of cAMP production in transfected S115 cells. Eur J Pharmacol 266:165-174.
17. 2C-C4 receptor subtypes in coupling to inhibition of cAMP accumulation. Biochem Biophys Res Commun 199:869-875.
18. 2B-C2 expressed in Sf9 cells couple to transduction pathway resulting in opposite effects on cAMP production. Eur J Pharmacol 290:75-83.
19. Kenakin T (1995) Pharmacological Proteus? Trends Pharmacol Sci 16:256-257.
20. Lefkowitz RJ, Cotecchia S, Samama P, and Costa T (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
21. 2-adrenergic receptors in human erythroleukemia (HEL) cells. Mol Pharmacol 32:258-265.
22. 2+ in human erythroleukemia cells. J Biol Chem 264:4986-4991.
23. 2-adrenergic receptor. Science (Washington DC) 264: 582-586.
24. Milligan G, Bond RA, and Lee M (1995) Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 16:10-13.
25. 2-adrenoceptor agonists: twist and agent polarity as design elements. Bioorg Med Chem Lett 4:459-462.
26. i-proteins in human erythroleukemia (HEL) cells: no evidence for a functional role of imidazoline receptors in modulating calcium. Biochem Pharmacol 49:187-196.
27. 2-Adrenoceptor regulation of adenylyl cyclase in CHO cells: dependence on receptor density, receptor subtype and current activity of adenylyl cyclase. Eur J Pharmacol 335:53-63.
28. Putney JW Jr and Bird GS (1993) The signal for capacitative calcium entry. Cell 75:199-201.
29. 2-drenergic receptor. J Biol Chem 268:16483-16487.
30. Salomon Y, Londos C, and Rodbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548.
31. 2-adrenergic receptor. Mol Pharmacol 45:390-394.
32. Sato M, Ribas C, Hildebrandt JD, and Lanier SM (1996) Characterization of a G protein activator in the neuroblastoma-glioma cell hybrid NG108-15. J Biol Chem 271:30052-30060.
33. 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine. Eur J Pharmacol 195:193-199.
34. Scharff O (1981) Calmodulin-and its role in cellular activation. Cell Calcium 2:1-27.
35. 2+-ATPase in erythrocyte membranes. Biochim Biophys Acta 691:133-143.
36. 2D-subtype? Eur J Pharmacol 219:203-210.
37. 2-adrenoceptors in rat atrium, vas deferens and submandibular gland. Eur J Pharmacol 211:251-256.
38. 2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol Pharmacol 45:524-531.
39. 1B receptor subtype. J Biol Chem 269:27925-27931.
40. 2-adrenoceptor agonist. Eur J Pharmacol 150:9-14.